Article
A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19
2020-05-29
Abstract excerpt
<title>Abstract</title> <p>BackgroundIn late December 2019, the coronavirus disease 2019 (COVID-19) first outbroke in Wuhan city, China, and has now become a global pandemic. However, there is no specific antiviral treatment for COVID-19.MethodsThis study was approved by the Ethics Committee of the Ninth Hospital of Nanchang. This study enrolled 33 COVID-19 patients in the nineth hospital of Nanchang from January...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 57cb66c0-8186-5aca-be4a-6c54569981ac
- DOI
- 10.21203/rs.3.rs-28376/v1
